Large-scale testing (Phase 3)Study completedNCT02015234
What this trial is testing
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
Who this might be right for
Primary Fibromyalgia
Tonix Pharmaceuticals, Inc. 158